{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T01:02:51Z","timestamp":1744333371623},"reference-count":52,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,14]]},"DOI":"10.7759\/cureus.26851","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T16:26:00Z","timestamp":1657815960000},"source":"Crossref","is-referenced-by-count":1,"title":["A Comprehensive Analysis of Myocarditis in Formerly Healthy Individuals Following SARS-CoV-2 Vaccination (COVID-19 Immunization)"],"prefix":"10.7759","author":[{"given":"Kamal","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smeet","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeel","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpen B","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinish S","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darshini B","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyank","family":"Chokshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ansh","family":"Parbatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akanksha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwati","family":"Konat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.087","article-title":"Myocarditis following COVID-19 mRNA vaccination","volume":"39","author":"Abu Mouch S","year":"2021","unstructured":"Abu Mouch S, Roguin A, Hellou E, et al.. Myocarditis following COVID-19 mRNA vaccination. Vaccine. 2021, 39:3790-3. 10.1016\/j.vaccine.2021.05.087","journal-title":"Vaccine"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13443","article-title":"Myocarditis and pericarditis after vaccination for COVID-19","volume":"326","author":"Diaz GA","year":"2021","unstructured":"Diaz GA, Parsons GT, Gering SK, Meier AR, Hutchinson IV, Robicsek A. Myocarditis and pericarditis after vaccination for COVID-19. JAMA. 2021, 326:1210-2. 10.1001\/jama.2021.13443","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000745","article-title":"Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association","volume":"141","author":"Kociol RD","year":"2020","unstructured":"Kociol RD, Cooper LT, Fang JC, et al.. Recognition and initial management of fulminant myocarditis: a scientific statement from the American Heart Association. Circulation. 2020, 141:e69-92. 10.1161\/CIR.0000000000000745","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.04.063","article-title":"Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction","volume":"74","author":"Ammirati E","year":"2019","unstructured":"Ammirati E, Veronese G, Brambatti M, et al.. Fulminant versus acute nonfulminant myocarditis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2019, 74:299-311. 10.1016\/j.jacc.2019.04.063","journal-title":"J Am Coll Cardiol"},{"key":"ref5","unstructured":"Centers for Disease Control and Prevention. ACIP presentation slides: August 30, 2021 meeting. (2021). Accessed: March 2, 2022: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/slides-2021-08-30.html."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou F","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al.. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020, 395:1054-62. 10.1016\/S0140-6736(20)30566-3","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.11.6710","article-title":"Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease","volume":"178","author":"Frisancho-Kiss S","year":"2007","unstructured":"Frisancho-Kiss S, Davis SE, Nyland JF, et al.. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease. J Immunol. 2007, 178:6710-4. 10.4049\/jimmunol.178.11.6710","journal-title":"J Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.008968","article-title":"Elevated sera sST2 is associated with heart failure in men \u226450 years old with myocarditis","volume":"8","author":"Coronado MJ","year":"2019","unstructured":"Coronado MJ, Bruno KA, Blauwet LA, et al.. Elevated sera sST2 is associated with heart failure in men \u226450 years old with myocarditis. J Am Heart Assoc. 2019, 8:e008968. 10.1161\/JAHA.118.008968","journal-title":"J Am Heart Assoc"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster ME","year":"2022","unstructured":"Oster ME, Shay DK, Su JR, et al.. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022, 327:331-40. 10.1001\/jama.2021.24110","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002681","article-title":"COVID-19 mRNA vaccine and myocarditis","volume":"8","author":"Singh B","year":"2021","unstructured":"Singh B, Kaur P, Cedeno L, et al.. COVID-19 mRNA vaccine and myocarditis. Eur J Case Rep Intern Med. 2021, 8:002681. 10.12890\/2021_002681","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02183-3","article-title":"Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report","volume":"21","author":"Hasnie AA","year":"2021","unstructured":"Hasnie AA, Hasnie UA, Patel N, Aziz MU, Xie M, Lloyd SG, Prabhu SD. Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC Cardiovasc Disord. 2021, 21:375. 10.1186\/s12872-021-02183-3","journal-title":"BMC Cardiovasc Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/children8070607","article-title":"Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?","volume":"8","author":"Das BB","year":"2021","unstructured":"Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and pericarditis following mRNA COVID-19 vaccination: what do we know so far?. Children (Basel). 2021, 8:10.3390\/children8070607","journal-title":"Children (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.055891","article-title":"Myocarditis temporally associated with COVID-19 vaccination","volume":"144","author":"Rosner CM","year":"2021","unstructured":"Rosner CM, Genovese L, Tehrani BN, et al.. Myocarditis temporally associated with COVID-19 vaccination. Circulation. 2021, 144:502-5. 10.1161\/CIRCULATIONAHA.121.055891","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.055913","article-title":"Myocarditis after BNT162b2 and mRNA-1273 vaccination","volume":"144","author":"Larson KF","year":"2021","unstructured":"Larson KF, Ammirati E, Adler ED, et al.. Myocarditis after BNT162b2 and mRNA-1273 vaccination. Circulation. 2021, 144:506-8. 10.1161\/CIRCULATIONAHA.121.055913","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.15576","article-title":"Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines","volume":"13","author":"Vidula MK","year":"2021","unstructured":"Vidula MK, Ambrose M, Glassberg H, Chokshi N, Chen T, Ferrari VA, Han Y. Myocarditis and other cardiovascular complications of the mRNA-based COVID-19 vaccines. Cureus. 2021, 13:e15576. 10.7759\/cureus.15576","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e229","article-title":"Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination","volume":"36","author":"Kim IC","year":"2021","unstructured":"Kim IC, Kim H, Lee HJ, Kim JY, Kim JY. Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination. J Korean Med Sci. 2021, 36:e229. 10.3346\/jkms.2021.36.e229","journal-title":"J Korean Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2021.100042","article-title":"Myocarditis following mRNA vaccination against SARS-CoV-2, a case series","volume":"8","author":"King WW","year":"2021","unstructured":"King WW, Petersen MR, Matar RM, Budweg JB, Cuervo Pardo L, Petersen JW. Myocarditis following mRNA vaccination against SARS-CoV-2, a case series. Am Heart J Plus. 2021, 8:100042. 10.1016\/j.ahjo.2021.100042","journal-title":"Am Heart J Plus"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2021.08.018","article-title":"Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients","volume":"340","author":"Abbate A","year":"2021","unstructured":"Abbate A, Gavin J, Madanchi N, et al.. Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients. Int J Cardiol. 2021, 340:119-21. 10.1016\/j.ijcard.2021.08.018","journal-title":"Int J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2021.06.003","article-title":"A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2","volume":"14","author":"Dickey JB","year":"2021","unstructured":"Dickey JB, Albert E, Badr M, et al.. A series of patients with myocarditis following SARS-CoV-2 vaccination with mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging. 2021, 14:1862-3. 10.1016\/j.jcmg.2021.06.003","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2021.07.008","article-title":"Acute myocarditis following mRNA-1273 SARS-CoV-2 vaccination","volume":"3","author":"Williams CB","year":"2021","unstructured":"Williams CB, Choi JI, Hosseini F, Roberts J, Ramanathan K, Ong K. Acute myocarditis following mRNA-1273 SARS-CoV-2 vaccination. CJC Open. 2021, 3:1410-2. 10.1016\/j.cjco.2021.07.008","journal-title":"CJC Open"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2021.04.005","article-title":"Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19","volume":"74","author":"Bautista Garc\u00eda J","year":"2021","unstructured":"Bautista Garc\u00eda J, Pe\u00f1a Ortega P, Bonilla Fern\u00e1ndez JA, C\u00e1rdenes Le\u00f3n A, Ram\u00edrez Burgos L, Caballero Dorta E. Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19. Rev Esp Cardiol (Engl Ed). 2021, 74:812-4. 10.1016\/j.rec.2021.04.005","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2021.07.005","article-title":"Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine","volume":"74","author":"Ram\u00edrez-Garc\u00eda A","year":"2021","unstructured":"Ram\u00edrez-Garc\u00eda A, Lozano Jim\u00e9nez S, Darnaude Xim\u00e9nez I, Gil Cacho A, Aguado-Noya R, Segovia Cubero J. Pericarditis after administration of the BNT162b2 mRNA COVID-19 vaccine. Rev Esp Cardiol (Engl Ed). 2021, 74:1120-2. 10.1016\/j.rec.2021.07.005","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piab060","article-title":"Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine","volume":"10","author":"Tano E","year":"2021","unstructured":"Tano E, San Martin S, Girgis S, Martinez-Fernandez Y, Sanchez Vegas C. Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccine. J Pediatric Infect Dis Soc. 2021, 10:962-6. 10.1093\/jpids\/piab060","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021211766","article-title":"Myocarditis following COVID-19 vaccination","volume":"301","author":"Isaak A","year":"2021","unstructured":"Isaak A, Feisst A, Luetkens JA. Myocarditis following COVID-19 vaccination. Radiology. 2021, 301:E378-9. 10.1148\/radiol.2021211766","journal-title":"Radiology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211029230","article-title":"Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from Vaccine Adverse Events Reporting System database","volume":"12","author":"Deb A","year":"2021","unstructured":"Deb A, Abdelmalek J, Iwuji K, Nugent K. Acute myocardial injury following COVID-19 vaccination: a case report and review of current evidence from Vaccine Adverse Events Reporting System database. J Prim Care Community Health. 2021, 12:21501327211029230. 10.1177\/21501327211029230","journal-title":"J Prim Care Community Health"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14322","article-title":"Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: a case report","volume":"28","author":"McLean K","year":"2021","unstructured":"McLean K, Johnson TJ. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: a case report. Acad Emerg Med. 2021, 28:918-21. 10.1111\/acem.14322","journal-title":"Acad Emerg Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056038","article-title":"In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine","volume":"144","author":"Muthukumar A","year":"2021","unstructured":"Muthukumar A, Narasimhan M, Li QZ, et al.. In-depth evaluation of a case of presumed myocarditis after the second dose of COVID-19 mRNA vaccine. Circulation. 2021, 144:487-98. 10.1161\/CIRCULATIONAHA.121.056038","journal-title":"Circulation"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2021.e01197","article-title":"Acute myocarditis following administration of BNT162b2 vaccine","volume":"25","author":"Habib MB","year":"2021","unstructured":"Habib MB, Hamamyh T, Elyas A, Altermanini M, Elhassan M. Acute myocarditis following administration of BNT162b2 vaccine. IDCases. 2021, 25:e01197. 10.1016\/j.idcr.2021.e01197","journal-title":"IDCases"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2021.06.019","article-title":"Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases","volume":"78","author":"Mansour J","year":"2021","unstructured":"Mansour J, Short RG, Bhalla S, Woodard PK, Verma A, Robinson X, Raptis DA. Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases. Clin Imaging. 2021, 78:247-9. 10.1016\/j.clinimag.2021.06.019","journal-title":"Clin Imaging"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.06.051","article-title":"Myocarditis after BNT162b2 vaccination in a healthy male","volume":"50","author":"Watkins K","year":"2021","unstructured":"Watkins K, Griffin G, Septaric K, Simon EL. Myocarditis after BNT162b2 vaccination in a healthy male. Am J Emerg Med. 2021, 50:815.e1-2. 10.1016\/j.ajem.2021.06.051","journal-title":"Am J Emerg Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2021.06.035","article-title":"Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent","volume":"238","author":"Minocha PK","year":"2021","unstructured":"Minocha PK, Better D, Singh RK, Hoque T. Recurrence of acute myocarditis temporally associated with receipt of the mRNA coronavirus disease 2019 (COVID-19) vaccine in a male adolescent. J Pediatr. 2021, 238:321-3. 10.1016\/j.jpeds.2021.06.035","journal-title":"J Pediatr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2021.05.033","article-title":"Myocarditis following COVID-19 vaccination","volume":"16","author":"Albert E","year":"2021","unstructured":"Albert E, Aurigemma G, Saucedo J, Gerson DS. Myocarditis following COVID-19 vaccination. Radiol Case Rep. 2021, 16:2142-5. 10.1016\/j.radcr.2021.05.033","journal-title":"Radiol Case Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2021.05.010","article-title":"Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?","volume":"37","author":"D'Angelo T","year":"2021","unstructured":"D'Angelo T, Cattafi A, Carerj ML, et al.. Myocarditis after SARS-CoV-2 vaccination: a vaccine-induced reaction?. Can J Cardiol. 2021, 37:1665-7. 10.1016\/j.cjca.2021.05.010","journal-title":"Can J Cardiol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102205","article-title":"COVID-19 vaccine-induced myocarditis: case report with literature review","volume":"15","author":"Nassar M","year":"2021","unstructured":"Nassar M, Nso N, Gonzalez C, et al.. COVID-19 vaccine-induced myocarditis: case report with literature review. Diabetes Metab Syndr. 2021, 15:102205. 10.1016\/j.dsx.2021.102205","journal-title":"Diabetes Metab Syndr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021-052478","article-title":"Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination","volume":"148","author":"Marshall M","year":"2021","unstructured":"Marshall M, Ferguson ID, Lewis P, et al.. Symptomatic acute myocarditis in 7 adolescents after Pfizer-BioNTech COVID-19 vaccination. Pediatrics. 2021, 148:10.1542\/peds.2021-052478","journal-title":"Pediatrics"},{"key":"ref36","unstructured":"World Health Organization. WHO coronavirus (COVID-19) dashboard. (2022). https:\/\/covid19.who.int\/."},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.310221","article-title":"Inflammatory cardiomyopathic syndromes","volume":"121","author":"Trachtenberg BH","year":"2017","unstructured":"Trachtenberg BH, Hare JM. Inflammatory cardiomyopathic syndromes. Circ Res. 2017, 121:803-18. 10.1161\/CIRCRESAHA.117.310221","journal-title":"Circ Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvz026","article-title":"Cardiovascular toxicities associated with immune checkpoint inhibitors","volume":"115","author":"Hu JR","year":"2019","unstructured":"Hu JR, Florido R, Lipson EJ, et al.. Cardiovascular toxicities associated with immune checkpoint inhibitors. Cardiovasc Res. 2019, 115:854-68. 10.1093\/cvr\/cvz026","journal-title":"Cardiovasc Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000155616.07901.35","article-title":"High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \"idiopathic\" left ventricular dysfunction","volume":"111","author":"K\u00fchl U","year":"2005","unstructured":"K\u00fchl U, Pauschinger M, Noutsias M, et al.. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with \"idiopathic\" left ventricular dysfunction. Circulation. 2005, 111:887-93. 10.1161\/01.CIR.0000155616.07901.35","journal-title":"Circulation"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/351979","article-title":"Myocarditis associated with influenza A H1N1pdm2009","volume":"2012","author":"Ukimura A","year":"2012","unstructured":"Ukimura A, Satomi H, Ooi Y, Kanzaki Y. Myocarditis associated with influenza A H1N1pdm2009. Influenza Res Treat. 2012, 2012:351979. 10.1155\/2012\/351979","journal-title":"Influenza Res Treat"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1899","article-title":"SARS-CoV-2-related myocarditis-like syndromes Shakespeare's question: what's in a name?","volume":"22","author":"Van Linthout S","year":"2020","unstructured":"Van Linthout S, Klingel K, Tsch\u00f6pe C. SARS-CoV-2-related myocarditis-like syndromes Shakespeare's question: what's in a name?. Eur J Heart Fail. 2020, 22:922-5. 10.1002\/ejhf.1899","journal-title":"Eur J Heart Fail"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al.. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020, 395:497-506. 10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8925","article-title":"Cytokine release syndrome in severe COVID-19","volume":"368","author":"Moore JB","year":"2020","unstructured":"Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020, 368:473-4. 10.1126\/science.abb8925","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016219","article-title":"Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection","volume":"9","author":"Guo J","year":"2020","unstructured":"Guo J, Huang Z, Lin L, Lv J. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc. 2020, 9:e016219. 10.1161\/JAHA.120.016219","journal-title":"J Am Heart Assoc"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-021-00662-w","article-title":"Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms","volume":"19","author":"Heymans S","year":"2022","unstructured":"Heymans S, Cooper LT. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol. 2022, 19:75-7. 10.1038\/s41569-021-00662-w","journal-title":"Nat Rev Cardiol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt B","year":"2021","unstructured":"Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021, 144:471-84. 10.1161\/CIRCULATIONAHA.121.056135","journal-title":"Circulation"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Del Valle DM","year":"2020","unstructured":"Del Valle DM, Kim-Schulze S, Huang HH, et al.. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med. 2020, 26:1636-43. 10.1038\/s41591-020-1051-9","journal-title":"Nat Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang Y","year":"2020","unstructured":"Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020, 11:1708. 10.3389\/fimmu.2020.01708","journal-title":"Front Immunol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11091647","article-title":"Myocardial pathology in COVID-19-associated cardiac injury: a systematic review","volume":"11","author":"Maiese A","year":"2021","unstructured":"Maiese A, Frati P, Del Duca F, et al.. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review. Diagnostics (Basel). 2021, 11:10.3390\/diagnostics11091647","journal-title":"Diagnostics (Basel)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26108","article-title":"Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis","volume":"93","author":"Aikawa T","year":"2021","unstructured":"Aikawa T, Takagi H, Ishikawa K, Kuno T. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis. J Med Virol. 2021, 93:51-5. 10.1002\/jmv.26108","journal-title":"J Med Virol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.05.001","article-title":"Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management","volume":"17","author":"Siripanthong B","year":"2020","unstructured":"Siripanthong B, Nazarian S, Muser D, et al.. Recognizing COVID-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm. 2020, 17:1463-71. 10.1016\/j.hrthm.2020.05.001","journal-title":"Heart Rhythm"},{"key":"ref52","unstructured":"Centers for Disease Control and Prevention. ACIP presentation slides: June 23-25, 2021 meeting. (2021). Accessed: January 4, 2022: https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/slides-2021-06.html."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99381-a-comprehensive-analysis-of-myocarditis-in-formerly-healthy-individuals-following-sars-cov-2-vaccination-covid-19-immunization","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:22Z","timestamp":1707507862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99381-a-comprehensive-analysis-of-myocarditis-in-formerly-healthy-individuals-following-sars-cov-2-vaccination-covid-19-immunization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":52,"URL":"https:\/\/doi.org\/10.7759\/cureus.26851","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,14]]}}}